Objective: This study aimed to observe and compare retinal vein diameter changes and other essential indicators in patients with high-risk proliferative diabetic retinopathy (PDR) treated with intravitreal injection of conbercept (IVC) combined with panretinal photocoagulation (PRP) versus PRP monotherapy.
Methods: A retrospective analysis was conducted on data from patients with high-risk PDR who received specific treatment and were followed up for 24 months. Among 82 patients with high-risk PDR, 50 eyes received PRP combined with IVC, whereas 32 eyes received PRP alone. During the 24-month follow-up period, changes in best-corrected visual acuity (BCVA), central foveal thickness (CFT), retinal vein diameter, number of microaneurysms (MA), neovascularization (NV) area, hard exudate (HE) area, size of the foveal avascular zone (FAZ), superficial capillary plexus (SCP) blood flow density, and adverse effects were recorded and compared between the two groups at baseline and at 6, 12, 18, and 24 months after treatment. The relationship between each observation index and vein diameter was also analyzed.
Results: During the 24-month follow up, significant improvements in the BCVA, CFT, retinal vein diameter, number of MAs, NV area, HE area, FAZ, and SCP were observed in the IVC+PRP group after treatment. The PRP group only showed significant reductions in NV and HE areas. The IVC+PRP group showed significant superiority over the PRP group in improving the vein diameter, number of MA, and HE area. However, no statistically significant difference in NV area reduction was found between the groups.
Conclusion: In the treatment of high-risk PDR, IVC+PRP therapy has a significant advantage over PRP monotherapy. IVC+PRP therapy may reverse diabetes-induced retinal vein changes, restoring morphology and function.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485612 | PMC |
| http://dx.doi.org/10.3389/fendo.2023.1218442 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Safety of intravitreal injections with the mobile laminar airflow device Operio after more than 10.000 injections.
Int Ophthalmol
March 2025
Department of Medicine Surgical, Section of Ophthalmology, University of Perugia, S. Maria Della Misericordia Hospital, 06156, Perugia, Italy.
Purpose: To evaluate the occurrence of complications following intravitreal injections (IVIs) performed in an outpatient clean room (OCR) equipped with the mobile laminar airflow device (LAF) Operio.
Methods: This retrospective study analyzed the data of 10,016 IVIs performed in an OCR from April 2023 to November 2024. All information of each patient was registered, such as diagnosis, drug injected and any occurring complication or adverse events such as endophthalmitis, intraocular inflammation, rhegmatogenous retinal detachment (RRD), vitreous hemorrhages and elevated intraocular pressure.
Vascular supply of the eye: clinical anatomy.
Med Hypothesis Discov Innov Ophthalmol
February 2025
Dokuz Eylul University, Department of Ophthalmology, Izmir, Turkiye.
Background: Eye function is vitally dependent on an adequate blood supply, primarily provided by the ophthalmic artery, an internal carotid artery branch. This review provides an overview of the vascular supply of the eye.
Methods: A targeted search of PubMed / MEDLINE was performed using the terms "central retinal vein," "central retinal artery," "internal carotid artery," "ophthalmic artery," "ophthalmic vein," "posterior ciliary arteries," "retinal capillaries," "vascular supply of the eye," "ocular vascular supply," "external carotid artery," and "vortex vein".
Retinal vasculitis associated with intravitreal bevacizumab injection: A case report.
Arch Soc Esp Oftalmol (Engl Ed)
March 2025
Clínica del Ojo, La Paz, Bolivia.
Anti-vascular endothelial growth factor drugs are the treatment of choice for macular edema due to venous occlusions. While rare, they have been associated with some uncommon adverse effects. We present a case of retinal vasculitis associated with bevacizumab in a72-year-old woman who presented to our clinic with sudden visual acuity loss in her left eye due to macular edema following central vein occlusion.
View Article and Find Full Text PDFTrends in the Incidence of Retinal Artery and Vein Occlusion Before and After COVID-19: A National Study in South Korea (2017-2022).
Am J Ophthalmol
March 2025
Department of Ophthalmology, Institute of Vision Research, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address:
Purpose: This study investigated the incidence of new retinal artery occlusion (RAO) and retinal vein occlusion (RVO) during the coronavirus disease-19 (COVID-19) pandemic compared to pre-outbreak periods in South Korea.
Design: Nationwide population-based retrospective cohort study PARTICIPANTS: Individuals diagnosed with RAO or RVO METHODS: We evaluated data from 326,154 patients diagnosed with RAO (n = 32,028), RVO (n = 304,405), or both (n = 10,279) from January 1, 2017 to December 31, 2022. We calculated the incidence rate ratios (IRR) of RAO and RVO using 2019 as the reference year, making comparisons across the total population and within age and sex subgroups.
Retinal vein occlusion risk prediction without fundus examination using a no-code machine learning tool for tabular data: a nationwide cross-sectional study from South Korea.
BMC Med Inform Decis Mak
March 2025
Department of Ophthalmology, Kim's Eye Hospital, Konyang University College of Medicine, Seoul, South Korea.
Background: Retinal vein occlusion (RVO) is a leading cause of vision loss globally. Routine health check-up data-including demographic information, medical history, and laboratory test results-are commonly utilized in clinical settings for disease risk assessment. This study aimed to develop a machine learning model to predict RVO risk in the general population using such tabular health data, without requiring coding expertise or retinal imaging.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!